KYMR Operating Cash Flow (Statement)
Kymera Therapeutics Inc · Operating Cash Flow (Statement)
KYMR Operating Cash Flow (Statement)
Latest reported-$236.76Mperiod ending
KYMR TTM Cash from Operations ($88.13M → -$236.76M)
TTM operating cash flow (statement)
High-resolution chart · PNG
KYMR operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -236,762,000 | |
| -242,581,000 | |
| -232,891,000 | |
| -227,928,000 | |
| -251,008,000 | |
| -234,060,000 | |
| -194,501,000 | |
| -124,672,000 | |
| -106,129,000 | |
| -98,449,000 | |
| -102,826,000 | |
| -150,407,000 | |
| -153,029,000 | |
| -156,758,000 | |
| -153,085,000 | |
| -151,901,000 | |
| -154,892,000 | |
| -146,418,000 | |
| -128,946,000 | |
| -110,662,000 | |
| 58,265,000 | |
| 77,364,000 | |
| 88,130,000 | |
| 97,397,000 | |
| -46,744,000 |